Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
greater disease » greater decrease (Expand Search), related disease (Expand Search), greater sense (Expand Search)
linear decrease » linear increase (Expand Search)
Showing 581 - 600 results of 24,497 for search '(( significantly ((greater disease) OR (linear decrease)) ) OR ( significant decrease decrease ))', query time: 0.61s Refine Results
  1. 581
    Primary and secondary efficacy end points (intention-to-treat population).

    Primary and secondary efficacy end points (intention-to-treat population). by Benjamin R. Lewis (22279166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  2. 582
    Demographic and clinical characteristics of participants at baseline.

    Demographic and clinical characteristics of participants at baseline. by Benjamin R. Lewis (22279166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  3. 583
    Change in QIDS-SR-16 and MBI-HSS-MP by Treatment Group.

    Change in QIDS-SR-16 and MBI-HSS-MP by Treatment Group. by Benjamin R. Lewis (22279166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  4. 584
    Change in Demoralization Scale (DSII) by Treatment Group.

    Change in Demoralization Scale (DSII) by Treatment Group. by Benjamin R. Lewis (22279166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  5. 585
    Change in Watt’s Connectedness Scale (WCS), General Connectedness by Treatment Group.

    Change in Watt’s Connectedness Scale (WCS), General Connectedness by Treatment Group. by Benjamin R. Lewis (22279166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  6. 586
    Study selection criteria.

    Study selection criteria. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  7. 587
    PICOS criteria for the SLR.

    PICOS criteria for the SLR. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  8. 588
    PRISMA flow chart.

    PRISMA flow chart. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  9. 589
    Diallyl Trisulfide, an Active Substance from Garlic, Inhibits Female Oviposition by Decreasing the Expression of the <i>OCT</i> Gene, which is Highly Expressed in the Spermathecal Gland of Sitotroga cerealella (Oliver)

    Diallyl Trisulfide, an Active Substance from Garlic, Inhibits Female Oviposition by Decreasing the Expression of the <i>OCT</i> Gene, which is Highly Expressed in the Spermathecal... by Wen-Han Yan (20539256)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  10. 590
    Diallyl Trisulfide, an Active Substance from Garlic, Inhibits Female Oviposition by Decreasing the Expression of the <i>OCT</i> Gene, which is Highly Expressed in the Spermathecal Gland of Sitotroga cerealella (Oliver)

    Diallyl Trisulfide, an Active Substance from Garlic, Inhibits Female Oviposition by Decreasing the Expression of the <i>OCT</i> Gene, which is Highly Expressed in the Spermathecal... by Wen-Han Yan (20539256)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  11. 591
    Hallmark significant GSVA results.

    Hallmark significant GSVA results. by Yinghao Ren (17915291)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  12. 592
    Modeling the relationship between cancer level in hemolymph and MarBTN in tank eDNA.

    Modeling the relationship between cancer level in hemolymph and MarBTN in tank eDNA. by Rachael M. Giersch (22331947)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  13. 593
    Adult <i>Shroom3</i><sup><i>+</i></sup><sup><i>/Gt</i></sup> hearts show decreased cardiomyocyte cross-sectional area.

    Adult <i>Shroom3</i><sup><i>+</i></sup><sup><i>/Gt</i></sup> hearts show decreased cardiomyocyte cross-sectional area. by Jennifer L. Carleton (22208916)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  14. 594
    Statistically significant and greater than 2-fold differentially used metabolites between WT and PrfA* <i>L. monocytogenes.</i>

    Statistically significant and greater than 2-fold differentially used metabolites between WT and PrfA* <i>L. monocytogenes.</i> by Matthew J. Freeman (21094788)

    Published 2025
    Save to List
    Saved in:
  15. 595
    A summary of calibration standards (n = 3).

    A summary of calibration standards (n = 3). by Ewa Paszkowska (21246702)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  16. 596
    The observed MRM reactions.

    The observed MRM reactions. by Ewa Paszkowska (21246702)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  17. 597
    Intra- and inter-day precision and accuracy.

    Intra- and inter-day precision and accuracy. by Ewa Paszkowska (21246702)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  18. 598
    Survey-weighted association of flavonoids and six subclasses intake with MASLD.

    Survey-weighted association of flavonoids and six subclasses intake with MASLD. by Yuwei He (1565941)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  19. 599
    Survey-weighted baseline characteristic of the study population by MASLD.

    Survey-weighted baseline characteristic of the study population by MASLD. by Yuwei He (1565941)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  20. 600
    Weighted Quantile Sum model regression index weights for the MASLD.

    Weighted Quantile Sum model regression index weights for the MASLD. by Yuwei He (1565941)

    Published 2025
    Subjects:
    Save to List
    Saved in:

Search Tools: